Lack of sterility assurance: Product leakage around the vial neck, which could potentially result in a lack of sterility assurance.
Advertisement
Recall Number
D-0398-2025
Classification
Class II
Status
Ongoing
Category
drug
Initiated
2025-04-18
Reported
2025-05-07
Distribution
Nationwide in the USA
Code Info
Lots, expiry: Lot 24025N0C0, 6/30/2025; Lot 24115N0C0, 10/31/2025; Lot 24116N0C0, 3/31/2026; Lot 24160N0C0, 12/31/2025; Lot 24217N0C0, 01/31/2026; Lot 24288N0C0, 04/30/2026; Lot 24331N0C0, 5/31/2026
Source: openFDA enforcement report. WhichRecall is not affiliated with the FDA. See our disclaimer.